Aliphatic Polyester‐Based Materials for Enhanced Cancer Immunotherapy
Ai Lin Chin, Xiaoqian Wang, Rong Tong
Source record
Source: Crossref
Published: Apr 28, 2021
DOI: 10.1002/mabi.202100087
Open original source ↗Source abstract
Abstract Poly(lactic acid) (PLA) and its copolymer, poly(lactic‐ co ‐glycolic acid) (PLGA), based aliphatic polyesters have been extensively used for biomedical applications, such as drug delivery system and tissue engineering, thanks to their biodegradability, benign toxicity, renewability, and adjustable mechanical properties. A rapidly growing field of cancer research, the development of therapeutic cancer vaccines or treatment modalities is aimed to deliver immunomodulatory signals that control the quality of immune responses against tumors. Herein, the progress and applications of PLA and PLGA are reviewed in delivering immunotherapeutics to treat cancers.
Evidence graph
No public relationships recorded yet.
Integrity note: This page is a factual metadata record created by deterministic ingestion. It is not a claim that the work moves a mathematical frontier or has been independently verified.